Challenges Slow Fermentation‑Based Bulk Medicine Projects

Implementation of bulk‑drug projects that rely on fermentation has encountered several obstacles, including lengthy land‑acquisition processes, environmental clearances, high utility costs and extended construction periods. Unlike chemical synthesis, fermentation depends on the biological activity of living cells, which grows naturally at a slower pace, causing project delays and affecting the timing of incentive payments that are tied to product sales.